Featured

News
BenevolentAI named as one of Fierce Medtech’s Fierce 15 of 2020
Mar 8, 2021
BenevolentAI was selected as one of the most promising private companies in the industry by Fierce Medtech in its Fierce 15 2020 list.
Blog
Joanna Shields speaks at the Global Partnership on Artificial Intelligence
Dec 11, 2020
BenevolentAI CEO Joanna Shields opened the final plenary of the Global Partnership on Artificial Intelligence (GPAI) summit with a powerful message on the future of AI.
News
COVID-19 and AI: An editorial review in EMBO from Michael B. Schultz, Daniel Vera, David A. Sinclair
Jul 1, 2020
David Sinclair and colleagues review our recent publication in the EMBO Molecular Medicine Journal in support of our AI-derived hypothesis for a potential treatment of COVID-19.
Blog
Future Fifty: joining forces to drive forward positive change
Mar 17, 2020
BenevolentAI today announced it has been selected for Tech Nation’s 2020 Future Fifty cohort. Our CEO Joanna Shields reflects on how joining forces with like-minded industry experts can serve as a powerful vehicle for transformation.
News
MIT Technology Review names BenevolentAI as a top 10 breakthrough tech
Feb 26, 2020
We’re proud to be recognised on this prestigious list for our work in AI-driven chemical design. Our compound design is based upon complex multiparametric optimisations which aim to cut the time and cost of designing a drug.